Please assess the completion status of the following clinical trial:

Trial Title: Bupropion and Weight Control for Smoking Cessation - 1

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Smoke at least 10 cigarettes per day~* Report concern about cessation-related weight gain~* Motivated to quit smoking~Exclusion Criteria:~* Currently pregnant, lactating, or no medically approved method of contraception~* Major medical problem~* History of seizure disorder or head injury~* Current or historical psychosis or bipolar disorder~* History of alcohol or substance abuse within previous year~* Current or historical eating disorder~* Use of antidepressant medication, monoamine oxidase inhibitor or lithium with previous month~* Multiple Drug Allergies~* Current major depressive disorder

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Bupropion and Weight Concerns intervention (Type: EXPERIMENTAL): Bupropion SR and a weight concerns psychosocial intervention
- Placebo and Weight Concerns (Type: ACTIVE_COMPARATOR): A matched placebo administered on same schedule as bupriopion and a weight concerns psychosocial intervention for smoking cesstion
- Bupropion and standard smoking cessation (Type: ACTIVE_COMPARATOR): Bupropion SR and a time and attention controlled smoking cessation intervention
- Placebo and standard smoking cessation (Type: PLACEBO_COMPARATOR): A matched placebo administered on same schedule as bupriopion and a time and attention controlled smoking cessation intervention

Based on this trial design, predict the completion outcome and termination type (if applicable).